Enming J. Su

1.8k total citations
36 papers, 1.4k citations indexed

About

Enming J. Su is a scholar working on Epidemiology, Cancer Research and Molecular Biology. According to data from OpenAlex, Enming J. Su has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 12 papers in Cancer Research and 10 papers in Molecular Biology. Recurrent topics in Enming J. Su's work include Acute Ischemic Stroke Management (12 papers), Protease and Inhibitor Mechanisms (12 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Enming J. Su is often cited by papers focused on Acute Ischemic Stroke Management (12 papers), Protease and Inhibitor Mechanisms (12 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Enming J. Su collaborates with scholars based in United States, Sweden and Switzerland. Enming J. Su's co-authors include Daniel A. Lawrence, Linda Fredriksson, Dudley K. Strickland, Ulf Eriksson, Jacqueline M. Cale, Donna M. Lombardi, Stephen M. Schwartz, Kris Mann, Manuel Yepes and Christer Betsholtz and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Enming J. Su

33 papers receiving 1.4k citations

Peers

Enming J. Su

NEURO

EPIDE

HEMAT

Fengyan Jin China

Eloy Cuadrado Spain

Anthony J. Arleth United States

Erika Folestad Sweden

Hitoshi Takagi Japan

Harold Thibodeaux United States

He Wu China

Hao Qin China

Bing–Qiao Zhao China

Izumi Suzuma Japan

Fengyan Jin China

Enming J. Su

660 ×1.3

298 ×0.9

199 ×0.7

NEURO

154 ×0.5

EPIDE

295 ×1.3

HEMAT

Citations per year, relative to Enming J. Su Enming J. Su (= 1×) peers Fengyan Jin

Countries citing papers authored by Enming J. Su

Since Specialization

Citations

This map shows the geographic impact of Enming J. Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enming J. Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enming J. Su more than expected).

Fields of papers citing papers by Enming J. Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enming J. Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enming J. Su. The network helps show where Enming J. Su may publish in the future.

Co-authorship network of co-authors of Enming J. Su

This figure shows the co-authorship network connecting the top 25 collaborators of Enming J. Su. A scholar is included among the top collaborators of Enming J. Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enming J. Su. Enming J. Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Su, Enming J., Mark Warnock, Kris Mann, et al.. (2026). A potent inhibitor of PAI-1, MDI-2517, mitigates disease severity in a preclinical systemic sclerosis model. JCI Insight.

Torrente, Daniel, Enming J. Su, Alí Francisco Citalán‐Madrid, et al.. (2025). The interaction of tPA with NMDAR1 drives neuroinflammation and neurodegeneration in α-synuclein-mediated neurotoxicity. Journal of Neuroinflammation. 22(1). 8–8. 3 indexed citations

Zeitelhofer, Manuel, Christina Stefanitsch, Daniel Torrente, et al.. (2025). PDGFRα inhibition reduces myofibroblast expansion in the fibrotic rim and enhances recovery after ischemic stroke. Journal of Clinical Investigation. 135(5).

Dabertrand, Fabrice, Nidia Quillinan, Enming J. Su, et al.. (2025). Micrometer‐scale tPA beads amplify plasmin generation for enhanced thrombolytic therapy. Bioengineering & Translational Medicine. 10(4). e70012–e70012.

Lathuilière, Aurélien, Enming J. Su, Yuyu Song, et al.. (2024). SORL1 is a receptor for tau that promotes tau seeding. Journal of Biological Chemistry. 300(6). 107313–107313. 7 indexed citations

Su, Enming J., et al.. (2023). Beta1-receptor blockade attenuates atherosclerosis progression following traumatic brain injury in apolipoprotein E deficient mice. PLoS ONE. 18(5). e0285499–e0285499. 3 indexed citations

Korin, Netanel, et al.. (2021). Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy. International Journal of Molecular Sciences. 22(21). 11477–11477. 13 indexed citations

Reinke, Ashley A., Mark Warnock, Enming J. Su, et al.. (2018). Dual-reporter high-throughput screen for small-molecule in vivo inhibitors of plasminogen activator inhibitor type-1 yields a clinical lead candidate. Journal of Biological Chemistry. 294(5). 1464–1477. 13 indexed citations

Su, Enming J., Chunzhang Cao, Linda Fredriksson, et al.. (2017). Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke. Acta Neuropathologica. 134(4). 585–604. 84 indexed citations

10.

Xiang, Jianming, et al.. (2016). Mechanisms Underlying Astrocyte Endfeet Swelling in Stroke. Acta neurochirurgica. Supplementum. 121. 19–22. 17 indexed citations

11.

Su, Enming J., Linda Fredriksson, Shannon J. Moore, et al.. (2015). Imatinib treatment reduces brain injury in a murine model of traumatic brain injury. Frontiers in Cellular Neuroscience. 9. 385–385. 39 indexed citations

12.

Sashindranath, Maithili, Maria Daglas, André L. Samson, et al.. (2012). The tissue-type plasminogen activator–plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans. Brain. 135(11). 3251–3264. 72 indexed citations

13.

Su, Enming J., et al.. (2011). The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model. Journal of Thrombosis and Haemostasis. 9(6). 1174–1182. 25 indexed citations

14.

Cale, Jacqueline M., et al.. (2010). Characterization of a Novel Class of Polyphenolic Inhibitors of Plasminogen Activator Inhibitor-1. Journal of Biological Chemistry. 285(11). 7892–7902. 35 indexed citations

15.

Hyman, Matthew C., Danica Petrovic‐Djergovic, Scott Visovatti, et al.. (2009). Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. Journal of Clinical Investigation. 119(5). 1136–1149. 98 indexed citations

16.

Su, Enming J., Linda Fredriksson, Gerald P. Schielke, Ulf Eriksson, & Daniel A. Lawrence. (2009). Tissue plasminogen activator-mediated PDGF signaling and neurovascular coupling in stroke. Journal of Thrombosis and Haemostasis. 7. 155–158. 30 indexed citations

17.

Su, Enming J., Linda Fredriksson, Melissa Geyer, et al.. (2008). Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nature Medicine. 14(7). 731–737. 359 indexed citations

18.

Stefansson, Steingrimur, Enming J. Su, Jacqueline M. Cale, et al.. (2007). The Contributions of Integrin Affinity and Integrin-Cytoskeletal Engagement in Endothelial and Smooth Muscle Cell Adhesion to Vitronectin. Journal of Biological Chemistry. 282(21). 15679–15689. 28 indexed citations

19.

Leik, Courtney E., et al.. (2006). Effect of pharmacologic plasminogen activator inhibitor‐1 inhibition on cell motility and tumor angiogenesis. Journal of Thrombosis and Haemostasis. 4(12). 2710–2715. 62 indexed citations

20.

Su, Enming J., Susan C. Stevenson, Michele L. Rollence, Jennifer Marshall-Neff, & Gene Liau. (2001). A Genetically Modified Adenoviral Vector Exhibits Enhanced Gene Transfer of Human Smooth Muscle Cells. Journal of Vascular Research. 38(5). 471–478. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact